These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 29902448

  • 1. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.
    Mustafa HJ, Sambatur EV, Pagani G, D'Antonio F, Maisonneuve E, Maurice P, Zwiers C, Verweij JEJT, Flood A, Shamshirsaz AA, Jouannic JM, Khalil A.
    Am J Obstet Gynecol; 2024 Oct; 231(4):417-429.e21. PubMed ID: 38588966
    [Abstract] [Full Text] [Related]

  • 3. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
    Moise KJ, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB, UNITY Study Group.
    N Engl J Med; 2024 Aug 08; 391(6):526-537. PubMed ID: 39115062
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
    Bellone M, Boctor FN.
    Transfusion; 2014 Aug 08; 54(8):2118-21. PubMed ID: 24673470
    [Abstract] [Full Text] [Related]

  • 5. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
    Lindenburg IT, van Kamp IL, van Zwet EW, Middeldorp JM, Klumper FJ, Oepkes D.
    BJOG; 2013 Jun 08; 120(7):847-52. PubMed ID: 23551577
    [Abstract] [Full Text] [Related]

  • 6. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC, Lopriore E, Zwiers C, Böhringer S, Janssen MWM, Oepkes D, De Haas M.
    Am J Obstet Gynecol; 2020 Jul 08; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [Abstract] [Full Text] [Related]

  • 7. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL, Govia R, Abou-Setta AM, Reid GJ, Hadfield M, Menard C, Noyd J, Main S, Zarychanski R.
    Transfus Apher Sci; 2015 Dec 08; 53(3):399-402. PubMed ID: 26321100
    [Abstract] [Full Text] [Related]

  • 8. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K, Endo M, Takahashi A, Doi Y, Sakuragi M, Kiyokawa T, Taniguchi H, Kitabatake Y, Handa M, Tomimatsu T, Tomiyama Y, Isaka Y, Kimura T.
    Int J Hematol; 2020 Jan 08; 111(1):149-154. PubMed ID: 31538326
    [Abstract] [Full Text] [Related]

  • 9. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A, Malhotra Singh B, Mandal K.
    Gynecol Obstet Invest; 2007 Jan 08; 63(3):176-80. PubMed ID: 17143009
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S, Nupponen I, Kuosmanen M, Aitokallio-Tallberg A, Ekholm E, Halmesmäki E, Orden MR, Palo P, Raudaskoski T, Tekay A, Tuimala J, Uotila J, Stefanovic V.
    Acta Obstet Gynecol Scand; 2015 Apr 08; 94(4):383-90. PubMed ID: 25603954
    [Abstract] [Full Text] [Related]

  • 11. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
    Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD.
    Fetal Diagn Ther; 2008 Apr 08; 23(2):159-63. PubMed ID: 18046076
    [Abstract] [Full Text] [Related]

  • 12. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, Estle L.
    Am J Obstet Gynecol; 1991 Nov 08; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC, Sá C, Gomes SC, Camacho LA, Moreira ME.
    Transfusion; 2013 Apr 08; 53(4):777-82. PubMed ID: 22882285
    [Abstract] [Full Text] [Related]

  • 14. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
    Zwiers C, van Kamp I, Oepkes D, Lopriore E.
    Expert Rev Hematol; 2017 Apr 08; 10(4):337-344. PubMed ID: 28277805
    [Abstract] [Full Text] [Related]

  • 15. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
    Patris M, Holoye A, Goldman D, De Coninck C, Colard M.
    Transfus Apher Sci; 2024 Apr 08; 63(2):103868. PubMed ID: 38238203
    [Abstract] [Full Text] [Related]

  • 16. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW, D'Souza R, Seaward PGR, Windrim R, Kelly EN, Ryan G.
    Fetal Diagn Ther; 2019 Apr 08; 46(6):425-432. PubMed ID: 31195389
    [Abstract] [Full Text] [Related]

  • 17. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.
    Poissonnier MH, Picone O, Brossard Y, Lepercq J.
    Fetal Diagn Ther; 2003 Apr 08; 18(6):467-71. PubMed ID: 14564122
    [Abstract] [Full Text] [Related]

  • 18. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ, León R, González-Macías C, Paz A, Prado F, Moreno LJ, Torrejón R.
    Transfus Apher Sci; 2014 Aug 08; 51(1):70-2. PubMed ID: 25312036
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
    Maisonneuve E, Dugas A, Friszer S, Toly-Ndour C, Cariot L, Dhombres F, Cortey A, Mailloux A, Carbonne B, Jouannic JM.
    J Gynecol Obstet Hum Reprod; 2021 Sep 08; 50(7):102119. PubMed ID: 33741541
    [Abstract] [Full Text] [Related]

  • 20. Treatment options for the fetus with alloimmune hemolytic disease.
    Bowman JM.
    Transfus Med Rev; 1990 Jul 08; 4(3):191-207. PubMed ID: 2134630
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.